DK1825865T3 - Stabiliserede præparater af serin-endopeptidaser, deres fremstilling og anvendelse - Google Patents

Stabiliserede præparater af serin-endopeptidaser, deres fremstilling og anvendelse

Info

Publication number
DK1825865T3
DK1825865T3 DK07002494T DK07002494T DK1825865T3 DK 1825865 T3 DK1825865 T3 DK 1825865T3 DK 07002494 T DK07002494 T DK 07002494T DK 07002494 T DK07002494 T DK 07002494T DK 1825865 T3 DK1825865 T3 DK 1825865T3
Authority
DK
Denmark
Prior art keywords
preparation
serine endopeptidases
stabilized preparations
salts
serine
Prior art date
Application number
DK07002494T
Other languages
Danish (da)
English (en)
Inventor
Andrea Dr Lichte
Verena Kraeling
Original Assignee
Siemens Healthcare Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics filed Critical Siemens Healthcare Diagnostics
Application granted granted Critical
Publication of DK1825865T3 publication Critical patent/DK1825865T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4833Thrombin (3.4.21.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4846Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21005Thrombin (3.4.21.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21006Coagulation factor Xa (3.4.21.6)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DK07002494T 2006-02-24 2007-02-06 Stabiliserede præparater af serin-endopeptidaser, deres fremstilling og anvendelse DK1825865T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006008613A DE102006008613A1 (de) 2006-02-24 2006-02-24 Stabilisierte Zubereitungen von Serin-Endopeptidasen, deren Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
DK1825865T3 true DK1825865T3 (da) 2009-04-20

Family

ID=38062568

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07002494T DK1825865T3 (da) 2006-02-24 2007-02-06 Stabiliserede præparater af serin-endopeptidaser, deres fremstilling og anvendelse

Country Status (8)

Country Link
US (1) US8124737B2 (fr)
EP (1) EP1825865B1 (fr)
JP (1) JP5096759B2 (fr)
AT (1) ATE420662T1 (fr)
CA (1) CA2579458C (fr)
DE (2) DE102006008613A1 (fr)
DK (1) DK1825865T3 (fr)
ES (1) ES2318803T3 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11229746B2 (en) 2006-06-22 2022-01-25 Excelsior Medical Corporation Antiseptic cap
US9078992B2 (en) 2008-10-27 2015-07-14 Pursuit Vascular, Inc. Medical device for applying antimicrobial to proximal end of catheter
US8545459B2 (en) 2009-02-25 2013-10-01 Teleflex Medical Incorporated Stabilized enzyme compositions
US9333280B2 (en) 2009-02-25 2016-05-10 Teleflex Medical Incorporated Stabilized enzyme compositions
US9388452B2 (en) * 2010-04-08 2016-07-12 Baxalta Incorporated Methods for modeling protein stability
US10166381B2 (en) 2011-05-23 2019-01-01 Excelsior Medical Corporation Antiseptic cap
AU2012261813B2 (en) * 2011-06-02 2017-04-20 Takeda Pharmaceutical Company Limited Formulations of recombinant furin
WO2012174127A1 (fr) * 2011-06-17 2012-12-20 Alvine Pharmaceuticals, Inc. Protéases destinées à dégrader le gluten
ES2797649T3 (es) 2011-07-12 2020-12-03 Icu Medical Inc Dispositivo para entrega de agente antimicrobiano en un catéter transdérmico
JP6174367B2 (ja) * 2013-04-26 2017-08-02 株式会社Lsiメディエンス トロンビン含有試薬及び測定方法
JP6185662B2 (ja) 2013-09-30 2017-08-23 テレフレックス メディカル インコーポレイテッド 安定化酵素組成物
AU2015252808B2 (en) 2014-05-02 2019-02-21 Excelsior Medical Corporation Strip package for antiseptic cap
FR3035120B1 (fr) * 2015-04-15 2020-02-07 Arcadophta Composition de plasminogenase immobilisee, procede de preparation, utilisation et dispositif comprenant une telle composition
WO2016182822A1 (fr) 2015-05-08 2016-11-17 Icu Medical, Inc. Raccords médicaux configurés pour recevoir des émetteurs d'agents thérapeutiques
WO2016201202A1 (fr) 2015-06-11 2016-12-15 Attwill Medical Solutions Inc. Dispositifs médicaux, systèmes et procédés utilisant des compositions à base d'antithrombine-héparine
EP4194043A1 (fr) 2016-10-14 2023-06-14 ICU Medical, Inc. Capuchons désinfectants pour raccords médicaux
WO2018204206A2 (fr) 2017-05-01 2018-11-08 Icu Medical, Inc. Raccords de fluide médical et procédés pour fournir des additifs dans des conduites de fluide médical
US11541221B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Tubing set with antimicrobial properties
US11541220B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Needleless connector with antimicrobial properties
US11534595B2 (en) 2018-11-07 2022-12-27 Icu Medical, Inc. Device for delivering an antimicrobial composition into an infusion device
US11517732B2 (en) 2018-11-07 2022-12-06 Icu Medical, Inc. Syringe with antimicrobial properties
US11400195B2 (en) 2018-11-07 2022-08-02 Icu Medical, Inc. Peritoneal dialysis transfer set with antimicrobial properties
AU2019384564B2 (en) 2018-11-21 2023-11-23 Icu Medical, Inc. Antimicrobial device comprising a cap with ring and insert
CN111500563B (zh) * 2020-05-08 2023-10-13 华兰生物工程重庆有限公司 一种从人血浆中纯化人凝血因子ⅶ的方法
CA3191718A1 (fr) * 2020-08-14 2022-02-17 Steuben Foods, Inc. Lait vegetal comprenant des compositions d'hydrolysat de proteines et de cations divalents ayant un gout et une stabilite ameliores
JP2024500319A (ja) 2020-12-07 2024-01-09 アイシーユー・メディカル・インコーポレーテッド 腹膜透析キャップ、システム、及び方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531778A1 (de) 1985-09-06 1987-03-12 Behringwerke Ag Verfahren zur bestimmung von proteaseinhibitoren
IL86417A (en) * 1987-05-22 1992-09-06 Armour Pharma Process for the inactivation of pathogens in biological or pharmaceutical material by mixing with aqueous solution containing a sugar(alcohol)and neutral salts as stabilizers
DK223389D0 (da) * 1989-05-05 1989-05-05 Ferrosan As Saarsvamp
WO1994028120A1 (fr) * 1991-05-10 1994-12-08 New York Blood Center, Inc. Procede de sterilisation de compositions biologiques et produit ainsi obtenu
US5308755A (en) 1992-06-08 1994-05-03 Research Corporation Technologies, Inc. Method for measuring heparin
DE4325872C1 (de) 1993-08-02 1994-08-04 Immuno Ag Virusinaktivierte Faktor Xa-Präparation
DE4416166C2 (de) 1994-05-06 1997-11-20 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen
DE19856443A1 (de) * 1998-12-08 2000-06-21 Centeon Pharma Gmbh Stabilisiertes Antithrombin III-Präparat
US20010031721A1 (en) * 1999-05-05 2001-10-18 Chandra Webb Highly concentrated, lyophilized, and liquid factor IX formulations
DE10022092A1 (de) 2000-05-08 2001-11-15 Aventis Behring Gmbh Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung
CA2544156C (fr) * 2003-10-29 2012-07-10 Altus Pharmaceuticals Inc. Proteases non pancreatiques destinees a reguler la concentration de cholecystokinine (cck) dans le plasma et a traiter la douleur
KR20150138427A (ko) * 2003-12-19 2015-12-09 노보 노르디스크 헬스 케어 악티엔게젤샤프트 인자 vii 폴리펩티드의 안정화된 조성물

Also Published As

Publication number Publication date
US8124737B2 (en) 2012-02-28
EP1825865A2 (fr) 2007-08-29
DE502007000371D1 (de) 2009-03-05
CA2579458C (fr) 2015-08-11
ES2318803T3 (es) 2009-05-01
EP1825865B1 (fr) 2009-01-14
DE102006008613A1 (de) 2007-08-30
US20070231315A1 (en) 2007-10-04
JP2007222169A (ja) 2007-09-06
CA2579458A1 (fr) 2007-08-24
EP1825865A3 (fr) 2007-12-12
JP5096759B2 (ja) 2012-12-12
ATE420662T1 (de) 2009-01-15

Similar Documents

Publication Publication Date Title
DE502007000371D1 (de) Stabilisierte Zubereitungen von Serin-Endopeptidasen, deren Herstellung und Verwendung
DK1698640T4 (da) Fremgangsmåde til stabilisering af antistof og antistofpræparat som stabiliseret opløsning.
HUE069590T2 (hu) PCSK9-gátló 6'-[[(1s,3s)-3-[[5-(difluormetoxi)-2-pirimidinil]amino]ciklopentil]amino][1(2h ),3'-bipiridin]-2-on és alkalmazására szolgáló eljárások
NO20076592L (no) Stabilt aktivt-stoffkompleks av salter av o-acetylsalicylsyre med basiske aminosyrer og glycin
BRPI0510674A (pt) variantes fc otimizadas
NO20084893L (no) Lyofiliserte terapeutiske peptistoffpreparater
EA201100727A1 (ru) Новый способ получения производных аминокислот
AU2011208075B2 (en) Stabilized antibody-containing liquid formulations
EA200802005A1 (ru) Стабилизированная связывающая молекула на основе стабилизированной молекулы scfv (варианты) и варианты получения и использования вышеназванных стабилизированных молекул
DK1449917T3 (da) Fremgangsmåde til L-aminosyrefremstilling under anvendelse af Escherichia
BR112012004391A2 (pt) adesivos de soja/ureia desnaturados com ácido estável e métodos para sua fabricação.
DK2051556T3 (da) Fremgangsmåde til forøget positionstilgængelighed
DK2080808T3 (da) Fremgangsmåde til fremstilling af l-aminosyre
EA200901109A1 (ru) Применение n-фениламидинов в качестве гербицидов
NO20090574L (no) Nye proteinkonjugater og fremgangsmater for fremstilling derav
EA200970896A1 (ru) ТВЕРДАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ВКЛЮЧАЮЩАЯ ПРОИЗВОДНОЕ БЕНЗИМИДАЗОЛ-7-КАРБОКСИЛАТА И pH РЕГУЛИРУЮЩИЙ АГЕНТ
FR2921572B1 (fr) Dispositif de conformation circulaire d'une piece de revolution, notamment un carter d'echappement d'une turbomachine
ATE483919T1 (de) Hülse
DK1745136T3 (da) Fremgangsmåde til enzymatisk fremstilling af (S)-3-cyano-5-methylhexansyre
TW200736576A (en) Alignment correction system and methods of use thereof
NO20082989L (no) Fremstiling av gamma-aminosyrer som har affinitet for alfa-2-deltaproteinet
DK1948754T3 (da) Sammensætning og fremgangsmåde til fortykkelse af tunge, vandige saltopløsninger
DK1988090T3 (da) Imidazol-5-carboxylsyrederivater, fremgangsmåder til fremstilling af disse og anvendelse deraf
BRPI0913174A2 (pt) Método para produzir um hidrolisado de proteína de trigo, hidrolisado de proteína de trigo, e, uso de um hidrolisado de proteína de trigo.
DK2251579T3 (da) Spændebånd